How shorted was NxStage Medical, Inc.? NXTM
NxStage Medical, Inc. left the US market in 2019. This page is a frozen archive of its reported short interest, ending 15 Feb 2019. The ticker NXTM no longer refers to this company and may since have been reassigned.
10.54%
of shares outstanding reported short · settlement date 15 Feb 2019
- vs previous report
- +2.60
- 5 reports (~10 weeks)
- +5.85
- days to cover
- 12.28
Markers along the chart's base: â–² results announced (an 8-K reporting results was filed) â–² quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.
Days to cover
FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.
Embed this chart
Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview
Cite this page
Plain
Wikipedia
BibTeX
Sector: Healthcare
History
| Settlement date | Short % | Change |
|---|---|---|
| 15 Feb 2019 | 10.54% | +2.60 |
| 31 Jan 2019 | 7.94% | +2.29 |
| 15 Jan 2019 | 5.65% | +0.14 |
| 31 Dec 2018 | 5.51% | +0.32 |
| 14 Dec 2018 | 5.19% | +0.50 |
| 30 Nov 2018 | 4.69% | +0.01 |
| 15 Nov 2018 | 4.68% | +0.24 |
| 31 Oct 2018 | 4.44% | +0.50 |
| 15 Oct 2018 | 3.94% | +0.01 |
| 28 Sep 2018 | 3.93% | +0.27 |
| 14 Sep 2018 | 3.66% | −0.12 |
| 31 Aug 2018 | 3.78% | +0.01 |
| 15 Aug 2018 | 3.77% | −0.18 |
| 31 Jul 2018 | 3.95% | −0.26 |
| 13 Jul 2018 | 4.21% | +0.18 |
| 29 Jun 2018 | 4.03% | −0.45 |
| 15 Jun 2018 | 4.48% | +0.59 |
| 31 May 2018 | 3.89% | +0.16 |
| 15 May 2018 | 3.73% | +0.43 |
| 30 Apr 2018 | 3.30% | −0.10 |
| 13 Apr 2018 | 3.40% | −2.06 |
| 29 Mar 2018 | 5.46% | +0.15 |
| 15 Mar 2018 | 5.31% | +0.03 |
| 28 Feb 2018 | 5.28% | −0.04 |
| 15 Feb 2018 | 5.32% | +0.70 |
| 31 Jan 2018 | 4.62% | +0.66 |
| 12 Jan 2018 | 3.96% | −0.11 |
| 29 Dec 2017 | 4.07% | – |
Newest first. Scroll inside the table for earlier dates, back to 29 Dec 2017.
Frequently asked questions
- How shorted was NxStage Medical, Inc.?
- NxStage Medical, Inc. left the US market in 2019. Its final reported figure was 10.54% of shares outstanding for settlement date 15 Feb 2019, per FINRA's consolidated short interest report; this page preserves its full history.
- What does this number include?
- FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
- Why does it only update twice a month?
- US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
- Is this NXTM's short float?
- No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
- What is NXTM's days to cover?
- 12.28 days for settlement date 15 Feb 2019: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
- Which funds are short?
- US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.